Strategic consulting for pharmaceutical, biotechnology, chemical & medical device companies. Trusted advisors to help navigate regulatory complexity, accelerate commercial launch, market access, global market expansion and commercial launch execution across global markets.
Founded by senior executives with deep roots across regulatory affairs, market access, commercial launch, and corporate & business development. Collabio operates at the intersection of science, strategy, and execution. Every partner on your project has navigated these environments before — at companies like GSK, Teva, Roche, Merck, and beyond.
Meet the full team→
Every engagement is led and delivered by experienced leaders. You work directly with the people whose names appear on the site — not passed down to junior consultants.
Direct experience in US, EU, UK, Brazil, and emerging markets — we understand the regulatory and commercial nuances that determine launch success.
FDA, EMA, MHRA, PMDA, BPR, GPSR, Cosmetics (CPNP & MoCRA) and ANVISA knowledge built from real submissions, not theory.
We work with companies who have fantastic products but need assistance to grow their market — potentially by introducing them into new international markets.
We work across areas of unmet medical need — including public health, therapeutics, and rare diseases — where regulatory and commercial complexity runs highest.
English, Portuguese, Spanish, French, and Mandarin — fluent in the language and the culture of your target markets.
Every deliverable, milestone, and document visible to your team at all times.
Every engagement begins with an NDA. Your pipeline, strategy, and proprietary data remain yours — protected throughout our work together.
Strategy and execution across the full product lifecycle, built for the regulatory and commercial complexity of global markets.
From regulatory mapping to launch roadmap — we turn complex markets into clear go-to-market plans, tailored to your product, your budget, and your timeline.
FDA, EMA, MHRA, PMDA, BPR, GPSR, Cosmetics (CPNP & MoCRA) and ANVISA — we navigate the full regulatory lifecycle so your product reaches market quicker, with the right strategy from day one through post-marketing.
End-to-end launch management — positioning, HCP engagement, KOL strategy, and market access. We stay in the room until you reach revenue, not just until we deliver a deck.
Scientific credibility that supports commercial success — evidence generation, publication strategy, and MSL programs designed for organisations preparing to launch.
C-suite and VP-level executives deployed into your organisation — delivering strategic momentum while you build permanent capabilities.
Decades of C-level relationships opened to you — accelerating deal timelines from years to months through trusted introductions and curated intelligence.
Regulatory complexity
is not a barrier.
It's our advantage.
Flexible engagement structures built around your needs — from project-based mandates to fully embedded partnerships.
Defined scope, fixed timeline, and transparent deliverables. Ideal for market entry assessments, regulatory gap analyses, or launch readiness audits.
Ongoing partnership with dedicated senior access. Monthly scope, priority response, and quarterly strategy reviews — continuity without the overhead of a full team.
A senior Collabio consultant integrates fully into your team — on-site or virtual — with complete access to your workflows, systems, and governance structures.
The Collabio Platform gives you real-time visibility into regulatory timelines, submission status, and market access milestones — without chasing email threads.
Whether you're entering a market or territory for the first time, or managing a complex multi-market launch, our senior team is ready to engage. No junior consultants. No generic frameworks.